ZERIA PHARMCEUTICAL CO., LTD. Logo

ZERIA PHARMCEUTICAL CO., LTD.

Develops and distributes prescription & consumer healthcare products in Europe and Asia.

4559 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
中央区日本橋小舟町10番11号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Zeria Pharmaceutical Co., Ltd. is a comprehensive healthcare company engaged in the research, development, manufacturing, and distribution of pharmaceutical products. The company operates through two primary business segments: Ethical Pharmaceuticals (prescription drugs) and Consumer Healthcare (over-the-counter products). Its consumer product portfolio includes nutritional health drugs, remedies for gastrointestinal diseases, cold remedies, and ophthalmic solutions. Zeria actively expands its R&D pipeline by in-licensing and developing drugs with established sales records in overseas markets, distributing its products internationally across Europe and Asia.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-07-03 07:19
Post-Annual General Meeting Information
臨時報告書
Japanese 23.2 KB
2025-06-26 03:01
Regulatory News Service
内部統制報告書-第71期(2024/04/01-2025/03/31)
Japanese 24.9 KB
2025-06-26 03:00
Regulatory News Service
確認書
Japanese 8.4 KB
2025-06-26 03:00
Annual Report
有価証券報告書-第71期(2024/04/01-2025/03/31)
Japanese 1.5 MB
2024-11-08 02:01
Report Publication Announcement
確認書
Japanese 8.3 KB
2024-11-08 02:00
Interim Report
半期報告書-第71期(2024/04/01-2025/03/31)
Japanese 204.2 KB
2024-07-03 03:44
Post-Annual General Meeting Information
臨時報告書
Japanese 23.8 KB
2024-06-27 07:11
Regulatory News Service
確認書
Japanese 8.4 KB
2024-06-27 07:09
Regulatory News Service
内部統制報告書-第70期(2023/04/01-2024/03/31)
Japanese 23.8 KB
2024-06-27 07:07
Annual Report
有価証券報告書-第70期(2023/04/01-2024/03/31)
Japanese 1.2 MB
2024-02-05 06:04
Quarterly Report
四半期報告書-第70期第3四半期(2023/10/01-2023/12/31)
Japanese 168.4 KB
2024-02-05 06:04
Report Publication Announcement
確認書
Japanese 8.3 KB
2023-11-06 07:10
Report Publication Announcement
確認書
Japanese 8.3 KB
2023-11-06 07:09
Interim Report
四半期報告書-第70期第2四半期(2023/07/01-2023/09/30)
Japanese 205.3 KB
2023-08-07 07:04
Report Publication Announcement
確認書
Japanese 8.3 KB

Automate Your Workflow. Get a real-time feed of all ZERIA PHARMCEUTICAL CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for ZERIA PHARMCEUTICAL CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
HYUNDAI BIOLAND Co.,Ltd. Logo
Develops natural biomaterials for cosmetics, nutraceuticals, and regenerative medicine globally.
South Korea 052260
Icure Pharmaceutical Incorporation Logo
Develops transdermal patches for dementia/Parkinson's and offers cosmetic ODM/OBM services.
South Korea 175250
Idorsia Ltd Logo
Develops and commercializes small-molecule medicines for CNS, cardiovascular, and immune disorders.
Switzerland IDIA
IL DONG PHARMACEUTICAL CO., LTD. Logo
Develops & manufactures pharmaceuticals, APIs, and offers CMO services for various diseases.
South Korea 249420
ILSUNG IS CO., LTD. Logo
Develops pharmaceuticals like antibiotics and anesthetics, expanding into CNS and GI therapies.
South Korea 003120
ILYANG PHARMACEUTICAL CO.,LTD Logo
Develops & manufactures drugs, vaccines & supplements for oncology & gastroenterology needs.
South Korea 007570
ImmuneOncia Therapeutics, Inc. Logo
A biopharma firm developing immune checkpoint inhibitors for cancer immunotherapy.
South Korea 424870
Immuno-Biological Laboratories Co., Ltd. Logo
Develops and supplies immunological reagents and diagnostics for research and drug discovery.
Japan 4570
Develops targeted dermatology & oncology therapies using unique formulation & delivery technologies.
United Kingdom N/A
Indivior PLC Logo
Develops pharmaceuticals for opioid use disorder, addiction, and serious mental illnesses.
United Kingdom INDV

Talk to a Data Expert

Have a question? We'll get back to you promptly.